Stock listing
PRME Stock Price, News, Filings & Events — Prime Medicine, Inc.
Selected listing: PRME · NASDAQ · USD · US
This page tracks Prime Medicine, Inc.'s PRME:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRME:NASDAQ. PRME:NASDAQ is the stock-level entry point for investors researching Prime Medicine, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prime Medicine, Inc. is a public company traded under the ticker PRME in the American market. With a market capitalization of approximately $532.8 million, the company focuses on advancing its innovative approaches in the field of medicine.

- Ticker
- PRME:NASDAQ
- Asset type
- Stock
- Market cap
- $567.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Prime Medicine, Inc. PRME:NASDAQ stock context
This page tracks Prime Medicine, Inc.'s PRME:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRME:NASDAQ. PRME:NASDAQ is the stock-level entry point for investors researching Prime Medicine, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prime Medicine, Inc. is a public company traded under the ticker PRME in the American market. With a market capitalization of approximately $532.8 million, the company focuses on advancing its innovative approaches in the field of medicine.
Latest news from Prime Medicine, Inc.
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
July 23, 2026
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
July 8, 2026
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulo...
June 22, 2026
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
June 18, 2026
Research Prime Medicine, Inc.
Prime Medicine, Inc. investor report
Review AI stock analysis and investor report context for PRME:NASDAQ.
Prime Medicine, Inc. company profile
View the public company page for Prime Medicine, Inc. on 6ix.
Prime Medicine, Inc. news
Read company news and market updates connected to Prime Medicine, Inc..
Prime Medicine, Inc. investor events
Find investor webinars, events, and replay context for Prime Medicine, Inc..